Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Metastatic basal cell carcinoma presenting as unilateral lymphedema

Identifieur interne : 000A64 ( PascalFrancis/Corpus ); précédent : 000A63; suivant : 000A65

Metastatic basal cell carcinoma presenting as unilateral lymphedema

Auteurs : M. M. Christian ; C. M. Murphy ; R. F. Jr Wagner

Source :

RBID : Pascal:98-0534312

Descripteurs français

English descriptors

Abstract

BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 1076-0512
A03   1    @0 Dermatol. surg.
A05       @2 24
A06       @2 10
A08 01  1  ENG  @1 Metastatic basal cell carcinoma presenting as unilateral lymphedema
A11 01  1    @1 CHRISTIAN (M. M.)
A11 02  1    @1 MURPHY (C. M.)
A11 03  1    @1 WAGNER (R. F. JR)
A14 01      @1 Department of Dermatology, The University of Texas Medical Branch at Galveston @2 Galveston, Texas @3 USA @Z 1 aut. @Z 3 aut.
A20       @1 1151-1153
A21       @1 1998
A23 01      @0 ENG
A43 01      @1 INIST @2 17417 @5 354000071340270160
A44       @0 0000 @1 © 1998 INIST-CNRS. All rights reserved.
A45       @0 10 ref.
A47 01  1    @0 98-0534312
A60       @1 P @3 CC @3 EC
A61       @0 A
A64   1    @0 Dermatologic surgery
A66 01      @0 USA
C01 01    ENG  @0 BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.
C02 01  X    @0 002B08A
C03 01  X  FRE  @0 Carcinome basocellulaire @5 01
C03 01  X  ENG  @0 Basal cell carcinoma @5 01
C03 01  X  SPA  @0 Carcinoma basocelular @5 01
C03 02  X  FRE  @0 Bras @5 02
C03 02  X  ENG  @0 Arm @5 02
C03 02  X  SPA  @0 Brazo @5 02
C03 03  X  FRE  @0 Métastase @5 03
C03 03  X  ENG  @0 Metastasis @5 03
C03 03  X  SPA  @0 Metástasis @5 03
C03 04  X  FRE  @0 Ganglion lymphatique @5 04
C03 04  X  ENG  @0 Lymph node @5 04
C03 04  X  SPA  @0 Ganglio linfático @5 04
C03 05  X  FRE  @0 Lymphoedème @5 05
C03 05  X  ENG  @0 Lymphedema @5 05
C03 05  X  SPA  @0 Linfedema @5 05
C03 06  X  FRE  @0 Etude cas @5 06
C03 06  X  ENG  @0 Case study @5 06
C03 06  X  SPA  @0 Estudio caso @5 06
C03 07  X  FRE  @0 Membre supérieur @5 07
C03 07  X  ENG  @0 Upper limb @5 07
C03 07  X  SPA  @0 Miembro superior @5 07
C03 08  X  FRE  @0 Homme @5 08
C03 08  X  ENG  @0 Human @5 08
C03 08  X  SPA  @0 Hombre @5 08
C07 01  X  FRE  @0 Peau pathologie @5 37
C07 01  X  ENG  @0 Skin disease @5 37
C07 01  X  SPA  @0 Piel patología @5 37
C07 02  X  FRE  @0 Tumeur maligne @5 38
C07 02  X  ENG  @0 Malignant tumor @5 38
C07 02  X  SPA  @0 Tumor maligno @5 38
N21       @1 349

Format Inist (serveur)

NO : PASCAL 98-0534312 INIST
ET : Metastatic basal cell carcinoma presenting as unilateral lymphedema
AU : CHRISTIAN (M. M.); MURPHY (C. M.); WAGNER (R. F. JR)
AF : Department of Dermatology, The University of Texas Medical Branch at Galveston/Galveston, Texas/Etats-Unis (1 aut., 3 aut.)
DT : Publication en série; Courte communication, note brève; Etude de cas, cas et faits cliniques; Niveau analytique
SO : Dermatologic surgery; ISSN 1076-0512; Etats-Unis; Da. 1998; Vol. 24; No. 10; Pp. 1151-1153; Bibl. 10 ref.
LA : Anglais
EA : BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.
CC : 002B08A
FD : Carcinome basocellulaire; Bras; Métastase; Ganglion lymphatique; Lymphoedème; Etude cas; Membre supérieur; Homme
FG : Peau pathologie; Tumeur maligne
ED : Basal cell carcinoma; Arm; Metastasis; Lymph node; Lymphedema; Case study; Upper limb; Human
EG : Skin disease; Malignant tumor
SD : Carcinoma basocelular; Brazo; Metástasis; Ganglio linfático; Linfedema; Estudio caso; Miembro superior; Hombre
LO : INIST-17417.354000071340270160
ID : 98-0534312

Links to Exploration step

Pascal:98-0534312

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Metastatic basal cell carcinoma presenting as unilateral lymphedema</title>
<author>
<name sortKey="Christian, M M" sort="Christian, M M" uniqKey="Christian M" first="M. M." last="Christian">M. M. Christian</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Dermatology, The University of Texas Medical Branch at Galveston</s1>
<s2>Galveston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Murphy, C M" sort="Murphy, C M" uniqKey="Murphy C" first="C. M." last="Murphy">C. M. Murphy</name>
</author>
<author>
<name sortKey="Wagner, R F Jr" sort="Wagner, R F Jr" uniqKey="Wagner R" first="R. F. Jr" last="Wagner">R. F. Jr Wagner</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Dermatology, The University of Texas Medical Branch at Galveston</s1>
<s2>Galveston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">98-0534312</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 98-0534312 INIST</idno>
<idno type="RBID">Pascal:98-0534312</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A64</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Metastatic basal cell carcinoma presenting as unilateral lymphedema</title>
<author>
<name sortKey="Christian, M M" sort="Christian, M M" uniqKey="Christian M" first="M. M." last="Christian">M. M. Christian</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Dermatology, The University of Texas Medical Branch at Galveston</s1>
<s2>Galveston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Murphy, C M" sort="Murphy, C M" uniqKey="Murphy C" first="C. M." last="Murphy">C. M. Murphy</name>
</author>
<author>
<name sortKey="Wagner, R F Jr" sort="Wagner, R F Jr" uniqKey="Wagner R" first="R. F. Jr" last="Wagner">R. F. Jr Wagner</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Department of Dermatology, The University of Texas Medical Branch at Galveston</s1>
<s2>Galveston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Dermatologic surgery</title>
<title level="j" type="abbreviated">Dermatol. surg.</title>
<idno type="ISSN">1076-0512</idno>
<imprint>
<date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Dermatologic surgery</title>
<title level="j" type="abbreviated">Dermatol. surg.</title>
<idno type="ISSN">1076-0512</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Arm</term>
<term>Basal cell carcinoma</term>
<term>Case study</term>
<term>Human</term>
<term>Lymph node</term>
<term>Lymphedema</term>
<term>Metastasis</term>
<term>Upper limb</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Carcinome basocellulaire</term>
<term>Bras</term>
<term>Métastase</term>
<term>Ganglion lymphatique</term>
<term>Lymphoedème</term>
<term>Etude cas</term>
<term>Membre supérieur</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>1076-0512</s0>
</fA01>
<fA03 i2="1">
<s0>Dermatol. surg.</s0>
</fA03>
<fA05>
<s2>24</s2>
</fA05>
<fA06>
<s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Metastatic basal cell carcinoma presenting as unilateral lymphedema</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>CHRISTIAN (M. M.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MURPHY (C. M.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>WAGNER (R. F. JR)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Dermatology, The University of Texas Medical Branch at Galveston</s1>
<s2>Galveston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>1151-1153</s1>
</fA20>
<fA21>
<s1>1998</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>17417</s2>
<s5>354000071340270160</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 1998 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>10 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>98-0534312</s0>
</fA47>
<fA60>
<s1>P</s1>
<s3>CC</s3>
<s3>EC</s3>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i2="1">
<s0>Dermatologic surgery</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B08A</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Carcinome basocellulaire</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Basal cell carcinoma</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Carcinoma basocelular</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Bras</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Arm</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Brazo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Métastase</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Metastasis</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Metástasis</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Ganglion lymphatique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Lymph node</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Ganglio linfático</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Etude cas</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Case study</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Estudio caso</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Membre supérieur</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Upper limb</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Miembro superior</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Homme</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Human</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>08</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Peau pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Skin disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Piel patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Tumeur maligne</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Malignant tumor</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Tumor maligno</s0>
<s5>38</s5>
</fC07>
<fN21>
<s1>349</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 98-0534312 INIST</NO>
<ET>Metastatic basal cell carcinoma presenting as unilateral lymphedema</ET>
<AU>CHRISTIAN (M. M.); MURPHY (C. M.); WAGNER (R. F. JR)</AU>
<AF>Department of Dermatology, The University of Texas Medical Branch at Galveston/Galveston, Texas/Etats-Unis (1 aut., 3 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Etude de cas, cas et faits cliniques; Niveau analytique</DT>
<SO>Dermatologic surgery; ISSN 1076-0512; Etats-Unis; Da. 1998; Vol. 24; No. 10; Pp. 1151-1153; Bibl. 10 ref.</SO>
<LA>Anglais</LA>
<EA>BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.</EA>
<CC>002B08A</CC>
<FD>Carcinome basocellulaire; Bras; Métastase; Ganglion lymphatique; Lymphoedème; Etude cas; Membre supérieur; Homme</FD>
<FG>Peau pathologie; Tumeur maligne</FG>
<ED>Basal cell carcinoma; Arm; Metastasis; Lymph node; Lymphedema; Case study; Upper limb; Human</ED>
<EG>Skin disease; Malignant tumor</EG>
<SD>Carcinoma basocelular; Brazo; Metástasis; Ganglio linfático; Linfedema; Estudio caso; Miembro superior; Hombre</SD>
<LO>INIST-17417.354000071340270160</LO>
<ID>98-0534312</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A64 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000A64 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:98-0534312
   |texte=   Metastatic basal cell carcinoma presenting as unilateral lymphedema
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024